Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Safinamide

🥰Excellent
Catalog No. T6651LCas No. 133865-89-1
Alias FCE-26743, FCE26743, FCE 26743, EMD-1195686, EMD1195686, EMD 1195686

Safinamide (FCE-26743) is a reversible and selective monoamine oxidase B (IC50 0.098μM) inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor (IC50 8μM). It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels. Potential additional uses of Safinamide might be Parkinson's disease, restless leg syndrome and epilepsy.

Safinamide

Safinamide

🥰Excellent
Purity: 99.9%
Catalog No. T6651LAlias FCE-26743, FCE26743, FCE 26743, EMD-1195686, EMD1195686, EMD 1195686Cas No. 133865-89-1
Safinamide (FCE-26743) is a reversible and selective monoamine oxidase B (IC50 0.098μM) inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor (IC50 8μM). It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels. Potential additional uses of Safinamide might be Parkinson's disease, restless leg syndrome and epilepsy.
Pack SizePriceAvailabilityQuantity
5 mg$31In Stock
10 mg$47In Stock
25 mg$82In Stock
50 mg$115In Stock
100 mg$162In Stock
500 mg$397In Stock
1 g$593In Stock
5 g$1,250In Stock
1 mL x 10 mM (in DMSO)$35In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Safinamide"

Select Batch
Purity:99.9%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Safinamide (FCE-26743) is a reversible and selective monoamine oxidase B (IC50 0.098μM) inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor (IC50 8μM). It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels. Potential additional uses of Safinamide might be Parkinson's disease, restless leg syndrome and epilepsy.
Targets&IC50
MAO-B:98 nM, MAO-A:580 μM
In vitro
Safinamide (1–300 µM) reduces the amplitude of the peak sodium currents in a concentration-dependent manner. When the holding potential is depolarized to -53 mV, the inhibitory effect of safinamide with a lower IC50 value (8 µM) in rat cortical neurons [1].
In vivo
Daily intraperitoneal injections of Safinamide 1mg/kg were administered for 14 days and the treatment prior to MCAO significantly ameliorates MCAO-caused cerebral infarction volume, neurological deficit, disruption of the brain-blood barrier (BBB), and impairs expression of tight junction protein occludin and ZO-1 in mice .Safinamide (intraperitoneal injection; 5 mg/kg, 15 mg/kg and 30 mg/kg) dose dependently inhibits the veratridine-induced GABA release and Glu release in vivo [2].
AliasFCE-26743, FCE26743, FCE 26743, EMD-1195686, EMD1195686, EMD 1195686
Chemical Properties
Molecular Weight302.34
FormulaC17H19FN2O2
Cas No.133865-89-1
SmilesO(CC1=CC(F)=CC=C1)C2=CC=C(CN[C@H](C(N)=O)C)C=C2
Relative Density.1.31g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (165.38 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3075 mL16.5377 mL33.0753 mL165.3767 mL
5 mM0.6615 mL3.3075 mL6.6151 mL33.0753 mL
10 mM0.3308 mL1.6538 mL3.3075 mL16.5377 mL
20 mM0.1654 mL0.8269 mL1.6538 mL8.2688 mL
50 mM0.0662 mL0.3308 mL0.6615 mL3.3075 mL
100 mM0.0331 mL0.1654 mL0.3308 mL1.6538 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Safinamide | purchase Safinamide | Safinamide cost | order Safinamide | Safinamide chemical structure | Safinamide in vivo | Safinamide in vitro | Safinamide formula | Safinamide molecular weight